Anti-ID2 antibody [4E12G5]
2
(1 Review)
|
(10 Publications)
Mouse Monoclonal ID2 antibody. Suitable for Flow Cyt, WB, IHC-P and reacts with Human samples. Cited in 10 publications. Immunogen corresponding to Recombinant Full Length Protein corresponding to Human ID2.
View Alternative Names
BHLHB26, ID2, DNA-binding protein inhibitor ID-2, Class B basic helix-loop-helix protein 26, Inhibitor of DNA binding 2, Inhibitor of differentiation 2, bHLHb26
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ID2 antibody [4E12G5] (AB166708)
Immunohistochemical analysis of paraffin embedded, DAB-stained Human breast cancer tissue labeling ID2 using ab166708 at a 1/200 dilution.
- Flow Cyt
Unknown
Flow Cytometry - Anti-ID2 antibody [4E12G5] (AB166708)
Flow cytometric analysis of ID2-labeled SK N SH cells (green) and negative control cells (red), using ab166708 at a 1/200 dilution.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ID2 antibody [4E12G5] (AB166708)
Immunohistochemical analysis of paraffin embedded, DAB-stained Human rectum cancer tissue labeling ID2 using ab166708 at a 1/200 dilution.
- WB
Unknown
Western blot - Anti-ID2 antibody [4E12G5] (AB166708)
All lanes:
Western blot - Anti-ID2 antibody [4E12G5] (ab166708) at 1/500 dilution
All lanes:
recombinant Human ID2 protein at 1 µg
Predicted band size: 14 kDa
false
- Flow Cyt
CiteAb
Flow Cytometry - Anti-ID2 antibody [4E12G5] (AB166708)
ID2 Flow cytometry/Cell sorting using Anti-ID2 antibody [4E12G5], ab166708. Publication image from Im, S. H. et al., 2018, Nat Commun, PubMed : 30413714.
Id2 is induced by IL-1β and IL-6 mediated signaling and downstream transcription factors STAT3, IRF4 and BATF in Treg cells. a Strategy for sorting TNaive, iTreg, and ex-Foxp3 TH17 cells from Foxp3Thy1.1 reporter mice (left). Flow cytometry analysis of IL-1r1 and IL-6rα among the TNaive, iTreg, and ex-Foxp3 TH17 cells (right). b, c FACS-sorted iTreg cells were re-stimulated with cytokines as indicated and analyzed for Id2 and Foxp3 mRNA expression by RT-qPCR (b) as well as for Id2 protein levels by flow cytometry (c). d Cartoon depicting highly putative STAT3, IRF4, and BATF binding motifs upstream of Id2 transcription start site (TSS). e Cartoon depicting Id2 promoter constructs used for luciferase reporter assay. f Id2 promoter-luciferase construct (−582/+36) were co-transfected with the combination of STAT3, IRF4 and BATF expressing vectors in HEK-293 T cells. Lysates were prepared 30 h after transfection, and luciferase activities were measured with the reporter activities normalized to renilla luciferase activity. *P 0.05, **P < 0.005, ***P < 0.001 (Student’s t-test). All data are representative three independent experiments with similar results (error bars, s.d.)
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
ID2 plays a role in cellular proliferation differentiation and development by modulating the activity of other transcription factors. It acts as part of a regulatory complex that blocks differentiation pathways allowing cells to maintain a proliferative and less differentiated state. ID2 often interacts with proteins like E2A and MyoD which are important for muscle cell differentiation. By regulating these factors ID2 influences the balance between cell growth and terminal differentiation.
Pathways
ID2 integrates into key signaling pathways particularly the TGF-beta and BMP signaling pathways. Through its interaction with the aforementioned bHLH transcription factors ID2 indirectly influences processes governed by these pathways. TGF-beta pathway for instance regulates cell growth and differentiation in a context-dependent manner incorporating ID2's regulatory effect on differentiation-suppressing transcription factors.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (10)
Recent publications for all applications. Explore the full list and refine your search
International journal of biological sciences 19:3324-3340 PubMed37497010
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in oncology 12:801300 PubMed35982951
2022
Applications
Unspecified application
Species
Unspecified reactive species
Physiological reports 9:e15119 PubMed34806343
2021
Applications
Unspecified application
Species
Unspecified reactive species
Medical science monitor : international medical jo 25:4438-4449 PubMed31201297
2019
Applications
Unspecified application
Species
Unspecified reactive species
Life sciences 227:64-73 PubMed31004656
2019
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 9:4736 PubMed30413714
2018
Applications
Unspecified application
Species
Unspecified reactive species
eLife 7: PubMed30095408
2018
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular biochemistry 119:9284-9294 PubMed30010211
2018
Applications
Unspecified application
Species
Unspecified reactive species
Oncotarget 8:113002-113012 PubMed29348884
2017
Applications
Unspecified application
Species
Unspecified reactive species
Cell 171:201-216.e18 PubMed28844693
2017
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com